
Exeliom Biosciences
At Exeliom Biosciences, we develop novel therapeutic approaches to unleashthe therapeutic potential of key players in the Microbiome - Host interactions to fightimmune-mediated diseases, starting with inflammatory bowel diseases
Series A ·
Amount not disclosed in a source on record.
All 2 rounds ↓Signals
Website registeredDec 17, 2018 (7 years old)
Funding rounds
- Series A · amount undisclosedSource: fundraisingfox.com
- Series A · amount undisclosedSource: fundraisingfox.com
- Website created
Companies like Exeliom Biosciences
MMirador Therapeutics$250M Series B+ · Jan 2026
AAtomwiseSeries B+ · Mar 2025GGranite Bio$30M Series A · Apr 2025
MMirae$5.4M Seed · Jul 2026
SSudo Bio$37M Series A · Sep 2022AAtavistik Bio$40M Series B+ · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/exeliom-biosciences (get a free API key).